SETD2: an epigenetic modifier with tumor suppressor functionality

In the past decade important progress has been made in our understanding of the epigenetic regulatory machinery. It has become clear that genetic aberrations in multiple epigenetic modifier proteins are associated with various types of cancer. Moreover, targeting the epigenome has emerged as a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Duns, Gerben, Westers, Helga, Sijmons, Rolf, van den Berg, Anke, Kok, Klaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226616/
https://www.ncbi.nlm.nih.gov/pubmed/27191891
http://dx.doi.org/10.18632/oncotarget.9368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226616/
https://www.ncbi.nlm.nih.gov/pubmed/27191891
http://dx.doi.org/10.18632/oncotarget.9368

Ejemplares similares